Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

ASA class is associated with early revision and reoperation after total hip arthroplasty: an analysis of the Geneva and Swedish Hip Arthroplasty Registries.

Ferguson RJ, Silman AJ, Combescure C, Bulow E, Odin D, Hannouche D, Glyn-Jones S, Rolfson O, L├╝bbeke A.

Acta Orthop. 2019 Aug;90(4):324-330. doi: 10.1080/17453674.2019.1605785. Epub 2019 Apr 30.

2.

Hip replacement.

Ferguson RJ, Palmer AJ, Taylor A, Porter ML, Malchau H, Glyn-Jones S.

Lancet. 2018 Nov 3;392(10158):1662-1671. doi: 10.1016/S0140-6736(18)31777-X. Review.

PMID:
30496081
3.

Validation of hip osteoarthritis diagnosis recording in the UK Clinical Practice Research Datalink.

Ferguson RJ, Prieto-Alhambra D, Walker C, Yu D, Valderas JM, Judge A, Griffiths J, Jordan KP, Peat G, Glyn-Jones S, Silman AJ.

Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):187-193. doi: 10.1002/pds.4673. Epub 2018 Oct 30.

PMID:
30375101
4.

Infographic: Primary stability of a short bone-conserving femoral stem.

Ferguson RJ, Broomfield JA, Malak TT, Palmer AJR, Whitwell D, Kendrick B, Taylor A, Glyn-Jones S.

Bone Joint J. 2018 Sep;100-B(9):1146-1147. doi: 10.1302/0301-620X.100B9.BJJ-2018-0863. No abstract available.

PMID:
30168763
5.

Primary stability of a short bone-conserving femoral stem: a two-year randomized controlled trial using radiostereometric analysis.

Ferguson RJ, Broomfield JA, Malak TT, Palmer AJR, Whitwell D, Kendrick B, Taylor A, Glyn-Jones S.

Bone Joint J. 2018 Sep;100-B(9):1148-1156. doi: 10.1302/0301-620X.100B9.BJJ-2017-1403.R1.

PMID:
30168759
6.

Examining the Utility of the New Raney Vocabulary Measure Alongside the WAIS-III.

Ferguson RJ, Roy-Charland A, Dickinson J.

J Psycholinguist Res. 2018 Aug;47(4):833-840. doi: 10.1007/s10936-017-9555-2.

PMID:
29380247
7.

Effects and moderators of psychosocial interventions on quality of life, and emotional and social function in patients with cancer: An individual patient data meta-analysis of 22 RCTs.

Kalter J, Verdonck-de Leeuw IM, Sweegers MG, Aaronson NK, Jacobsen PB, Newton RU, Courneya KS, Aitken JF, Armes J, Arving C, Boersma LJ, Braamse AMJ, Brandberg Y, Chambers SK, Dekker J, Ell K, Ferguson RJ, Gielissen MFM, Glimelius B, Goedendorp MM, Graves KD, Heiney SP, Horne R, Hunter MS, Johansson B, Kimman ML, Knoop H, Meneses K, Northouse LL, Oldenburg HS, Prins JB, Savard J, van Beurden M, van den Berg SW, Brug J, Buffart LM.

Psychooncology. 2018 Apr;27(4):1150-1161. doi: 10.1002/pon.4648. Epub 2018 Mar 15. Review.

8.

Cognitive behavioral therapy for cancer-related cognitive dysfunction.

Kucherer S, Ferguson RJ.

Curr Opin Support Palliat Care. 2017 Mar;11(1):46-51. doi: 10.1097/SPC.0000000000000247. Review.

9.

Methylphenidate and Memory and Attention Adaptation Training for Persistent Cognitive Symptoms after Traumatic Brain Injury: A Randomized, Placebo-Controlled Trial.

McDonald BC, Flashman LA, Arciniegas DB, Ferguson RJ, Xing L, Harezlak J, Sprehn GC, Hammond FM, Maerlender AC, Kruck CL, Gillock KL, Frey K, Wall RN, Saykin AJ, McAllister TW.

Neuropsychopharmacology. 2017 Aug;42(9):1766-1775. doi: 10.1038/npp.2016.261. Epub 2016 Nov 22.

10.

A randomized trial of videoconference-delivered cognitive behavioral therapy for survivors of breast cancer with self-reported cognitive dysfunction.

Ferguson RJ, Sigmon ST, Pritchard AJ, LaBrie SL, Goetze RE, Fink CM, Garrett AM.

Cancer. 2016 Jun 1;122(11):1782-91. doi: 10.1002/cncr.29891. Epub 2016 May 2.

11.

A cognitive behavioral intervention (HOBSCOTCH) improves quality of life and attention in epilepsy.

Caller TA, Ferguson RJ, Roth RM, Secore KL, Alexandre FP, Zhao W, Tosteson TD, Henegan PL, Birney K, Jobst BC.

Epilepsy Behav. 2016 Apr;57(Pt A):111-117. doi: 10.1016/j.yebeh.2016.01.024. Epub 2016 Mar 2.

PMID:
26943948
12.

Design and feasibility of a memory intervention with focus on self-management for cognitive impairment in epilepsy.

Caller TA, Secore KL, Ferguson RJ, Roth RM, Alexandre FP, Henegan PL, Harrington JJ, Jobst BC.

Epilepsy Behav. 2015 Mar;44:192-4. doi: 10.1016/j.yebeh.2014.12.036. Epub 2015 Feb 27.

PMID:
25731132
13.

Management of scrotal arteriovenous malformation with transcatheter embolisation coils and percutaneous sclerotherapy under angiographic guidance.

So WL, Chaganti J, Waugh R, Ferguson RJ.

J Med Imaging Radiat Oncol. 2015 Aug;59(4):468-70. doi: 10.1111/1754-9485.12261. Epub 2014 Dec 10.

PMID:
25492446
14.

Autologous umbilical cord blood infusion followed by oral docosahexaenoic acid and vitamin D supplementation for C-peptide preservation in children with Type 1 diabetes.

Haller MJ, Wasserfall CH, Hulme MA, Cintron M, Brusko TM, McGrail KM, Wingard JR, Theriaque DW, Shuster JJ, Ferguson RJ, Kozuch M, Clare-Salzler M, Atkinson MA, Schatz DA.

Biol Blood Marrow Transplant. 2013 Jul;19(7):1126-9. doi: 10.1016/j.bbmt.2013.04.011. Epub 2013 Apr 20.

15.

Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial.

Ferguson RJ, McDonald BC, Rocque MA, Furstenberg CT, Horrigan S, Ahles TA, Saykin AJ.

Psychooncology. 2012 Feb;21(2):176-86. doi: 10.1002/pon.1878. Epub 2010 Dec 2.

16.

Recent and remote spatial memory in mice treated with cytosine arabinoside.

Fremouw T, Fessler CL, Ferguson RJ, Burguete Y.

Pharmacol Biochem Behav. 2012 Jan;100(3):451-7. doi: 10.1016/j.pbb.2011.10.008. Epub 2011 Oct 12.

PMID:
22020055
17.

Preserved learning and memory in mice following chemotherapy: 5-Fluorouracil and doxorubicin single agent treatment, doxorubicin-cyclophosphamide combination treatment.

Fremouw T, Fessler CL, Ferguson RJ, Burguete Y.

Behav Brain Res. 2012 Jan 1;226(1):154-62. doi: 10.1016/j.bbr.2011.09.013. Epub 2011 Sep 14.

PMID:
21930159
18.
19.

Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy.

Ferguson RJ, McDonald BC, Saykin AJ, Ahles TA.

J Clin Oncol. 2007 Sep 1;25(25):3866-70.

20.

Cognitive-behavioral management of chemotherapy-related cognitive change.

Ferguson RJ, Ahles TA, Saykin AJ, McDonald BC, Furstenberg CT, Cole BF, Mott LA.

Psychooncology. 2007 Aug;16(8):772-7.

21.

Assessing the relationship between preterm delivery and various microorganisms recovered from the lower genital tract.

Edwards RK, Ferguson RJ, Reyes L, Brown M, Theriaque DW, Duff P.

J Matern Fetal Neonatal Med. 2006 Jun;19(6):357-63.

PMID:
16801313
22.

The interleukin-1 beta +3953 single nucleotide polymorphism: cervical protein concentration and preterm delivery risk.

Edwards RK, Ferguson RJ, Duff P.

Am J Reprod Immunol. 2006 Apr;55(4):259-64.

PMID:
16533337
23.

Posttraumatic stress disorder in primary care: prevalence and relationships with physical symptoms and medical utilization.

Gillock KL, Zayfert C, Hegel MT, Ferguson RJ.

Gen Hosp Psychiatry. 2005 Nov-Dec;27(6):392-9.

PMID:
16271653
24.

The interleukin-6--174 single nucleotide polymorphism: cervical protein production and the risk of preterm delivery.

Jamie WE, Edwards RK, Ferguson RJ, Duff P.

Am J Obstet Gynecol. 2005 Apr;192(4):1023-7.

PMID:
15846175
25.

Assessment of cervical antibody concentrations fails to enhance the value of cervical length as a predictor of preterm delivery.

Edwards RK, Ferguson RJ, Shuster JJ, Theriaque D, Gentry S, Duff P.

Am J Obstet Gynecol. 2005 Mar;192(3):887-91.

PMID:
15746687
26.

Psychometric update of the Functional Interference Estimate: a brief measure of pain functional interference.

Ferguson RJ, Seville J, Cole B, Hanscom B, Wasson JH, Johnson DJ, Ahles T.

J Pain Symptom Manage. 2004 Oct;28(4):389-95.

PMID:
15471657
27.

Cognitive effects of cytotoxic cancer chemotherapy: predisposing risk factors and potential treatments.

McAllister TW, Ahles TA, Saykin AJ, Ferguson RJ, McDonald BC, Lewis LD, Flashman LA, Rhodes CH.

Curr Psychiatry Rep. 2004 Oct;6(5):364-71. Review.

PMID:
15355759
28.

Low neuropsychologic performance among adult cancer survivors treated with chemotherapy.

Ferguson RJ, Ahles TA.

Curr Neurol Neurosci Rep. 2003 May;3(3):215-22. Review.

PMID:
12691626
29.

Distinguishing between excessive daytime sleepiness and fatigue: toward improved detection and treatment.

Pigeon WR, Sateia MJ, Ferguson RJ.

J Psychosom Res. 2003 Jan;54(1):61-9. Review.

PMID:
12505556
30.

Use of the reliable change index to evaluate clinical significance in SF-36 outcomes.

Ferguson RJ, Robinson AB, Splaine M.

Qual Life Res. 2002 Sep;11(6):509-16.

PMID:
12206571
31.

Health functioning impairments associated with posttraumatic stress disorder, anxiety disorders, and depression.

Zayfert C, Dums AR, Ferguson RJ, Hegel MT.

J Nerv Ment Dis. 2002 Apr;190(4):233-40.

PMID:
11960084
32.

uvrA is an acid-inducible gene involved in the adaptive response to low pH in Streptococcus mutans.

Hanna MN, Ferguson RJ, Li YH, Cvitkovitch DG.

J Bacteriol. 2001 Oct;183(20):5964-73.

34.
35.

Postconcussion syndrome following sports-related head injury: expectation as etiology.

Ferguson RJ, Mittenberg W, Barone DF, Schneider B.

Neuropsychology. 1999 Oct;13(4):582-9.

PMID:
10527067
36.

A novel transversion in the intron 5 donor splice junction of CYP2C19 and a sequence polymorphism in exon 3 contribute to the poor metabolizer phenotype for the anticonvulsant drug S-mephenytoin.

Ibeanu GC, Blaisdell J, Ferguson RJ, Ghanayem BI, Brosen K, Benhamou S, Bouchardy C, Wilkinson GR, Dayer P, Goldstein JA.

J Pharmacol Exp Ther. 1999 Aug;290(2):635-40.

PMID:
10411572
37.

Private body consciousness, anxiety and pain symptom reports of chronic pain patients.

Ferguson RJ, Ahles TA.

Behav Res Ther. 1998 May;36(5):527-35.

PMID:
9648328
38.

A new genetic defect in human CYP2C19: mutation of the initiation codon is responsible for poor metabolism of S-mephenytoin.

Ferguson RJ, De Morais SM, Benhamou S, Bouchardy C, Blaisdell J, Ibeanu G, Wilkinson GR, Sarich TC, Wright JM, Dayer P, Goldstein JA.

J Pharmacol Exp Ther. 1998 Jan;284(1):356-61.

PMID:
9435198
39.
40.

Recombinant expression and catalytic analysis of rapid and slow acetylator Syrian hamster chimeric NAT2 alleles.

Hein DW, Ferguson RJ, Doll MA, Deitz AC.

Arch Toxicol. 1997;71(5):306-13.

PMID:
9137809
41.
43.

Metabolic activation of carcinogenic arylamines by rapid acetylator, slow acetylator, and chimeric recombinant Syrian hamster NAT2 allozymes.

Hein DW, Doll MA, Ferguson RJ.

Proc West Pharmacol Soc. 1995;38:59-62. No abstract available.

PMID:
7480023
44.
45.
46.

Syrian hamster monomorphic N-acetyltransferase (NAT1) alleles: amplification, cloning, sequencing, and expression in E. coli.

Ferguson RJ, Doll MA, Rustan TD, Baumstark BR, Hein DW.

Pharmacogenetics. 1994 Apr;4(2):82-90.

PMID:
8081415
47.
48.
49.
50.

Supplemental Content

Loading ...
Support Center